SPIA
IRON icon

Steward Partners Investment Advisory’s Disc Medicine IRON Stock Holding History

Steward Partners Investment Advisory’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.6K Hold
528
– – ﹤0.01% 3097
2026
Q1 		$33.8K Hold
528
– – ﹤0.01% 2981
2025
Q4 		$41.9K Sell
528
-5
-0.9% -$422 ﹤0.01% 2767
2025
Q3 		$35.2K Hold
533
– – ﹤0.01% 2784
2025
Q2 		$28.2K Buy
533
+8
+2% +$376 ﹤0.01% 2763
2025
Q1 		$26.1K Hold
525
– – ﹤0.01% 2683
2024
Q4 		$33.3K Buy
525
+125
+31% +$7.23K ﹤0.01% 2549
2024
Q3 		$19.7K Hold
400
– – ﹤0.01% 2667
2024
Q2 		$18K Hold
400
– – ﹤0.01% 2581
2024
Q1 		$24.9K Sell
400
-200
-33% -$13K ﹤0.01% 2430
2023
Q4 		$34.7K Buy
600
+200
+50% +$10.2K ﹤0.01% 2137
2023
Q3 		$18.8K Hold
400
– – ﹤0.01% 2336
2023
Q2 		$17.8K Buy
400
+100
+33% +$3.55K ﹤0.01% 2349
2023
Q1 		$6.36K Buy
+300
New +$6.68K ﹤0.01% 2705

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Steward Partners Investment Advisory's IRON Position: Q2 2026 in Review

Steward Partners Investment Advisory held its Disc Medicine (IRON) position steady in Q2 2026 at 528 shares worth $38.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3097.

Steward Partners Investment Advisory first reported a position in IRON in Q1 2023 and has held it in 14 quarters since. The position peaked at $41.9K in Q4 2025. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Steward Partners Investment Advisory held 528 shares of Disc Medicine worth $38.6K as of Q2 2026.
  • Steward Partners Investment Advisory left its Disc Medicine share count unchanged in Q2 2026.
  • Disc Medicine made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #3097 holding.
  • Steward Partners Investment Advisory first reported a position in Disc Medicine in Q1 2023 and has held it in 14 quarters since.
  • Steward Partners Investment Advisory's Disc Medicine position peaked at $41.9K in Q4 2025.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.